期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 96 (4)
Background: The amyloid-beta(1-42) (A beta(42)) level is a biomarker that is widely used to evaluate individual cognitive dysfunction early in neurode......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 95 (1)
Background: The differences in positron emission tomography (PET) imaging among older adults with mild cognitive impairment (MCI), according to the re......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 96 (4)
Background: There is a need for clinical quality indicators (CQIs) that can be applied to dementia quality registries to monitor care outcomes for peo......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 93 (1)
Background: Cognitive and brain reserve refer to individual differences that allow some people to better withstand brain pathology than others. Althou......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 93 (2)
Mutations in ITM2B have been reported to be associated with several familial dementias, such as Familial British dementia and familial Danish dementia......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 91 (1)
Background: Most research on cerebrospinal fluid (CSF) neurofilament light protein (NfL) as a marker for neurodegeneration and neurogranin (Ng) for sy......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 94 (1)
Background: Dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) are likely to induce memory impairments from the prodromal stage but, to our ......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 96 (3)
Background: Behavioral and psychological symptoms of dementia (BPSD) bring complexity in the clinical management of people with dementia; therefore, i......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 93 (1)
Background: Research on posterior cortical atrophy (PCA) has focused on cognitive decline, especially visual processing deficits. However, few studies......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 91 (1)
Millions of patients worldwide are affected by Alzheimer's disease (AD), and the number of patients with AD is increasing. However, current treatment ......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 91 (1)
Background: Subjective cognitive decline (SCD) is considered to be a preliminary stage of dementia, and its prevalence is increasing with age. Objecti......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 96 (4)
Background: The cerebrospinal fluid (CSF) levels of tau phosphorylated at threonine 217 (p217tau) or 181 (p181tau), and neurofilament light chain (NfL......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 95 (3)
Background: Objective measurement of regional cortical atrophy in individual patients would be a highly desirable adjunct for diagnosis of degenerativ......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 91 (2)
Background: Cerebral small vessel disease (CSVD), which comprises the typical features of white matter hyperintensity (WMH) and Vichor-Robin spaces (V......
期刊： JOURNAL OF ALZHEIMERS DISEASE, 2023; 94 (2)
Background: The profile of naturally occurring antibodies to amyloid-beta (NAbs-A beta) is altered in patients with Alzheimer's disease (AD). However,......
